BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Expression Genetics, Inc. 

2215 Mock Road

Huntsville  Alabama  35801  U.S.A.
Phone: 256-512-0077 Fax: 256-512-0988


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Expression Genetics, Inc.'s EGEN-001 Named One of 10 Most Promising Oncology Products 9/5/2008 10:59:03 AM    More...
Expression Genetics, Inc. Raises $12 Million 8/5/2008 8:08:15 AM    More...
Expression Genetics, Inc. Specializing in DNA/RNAi Delivery and Therapeutics, Completes $12M Series B Financing 8/4/2008 6:13:49 AM    More...
Expression Genetics, Inc. Announces Further Clinical Advancement of its Gene-Based IL-12 Therapy Co-administered with Standard Chemotherapy for Treatment of Ovarian Cancer 7/20/2007 10:38:22 AM    More...
Expression Genetics, Inc. Receives Orphan Drug Grant from FDA for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer 5/3/2007 9:20:46 AM    More...
Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 4/16/2007 1:20:20 PM    More...
Expression Genetics, Inc. Announces EGEN-001 Cancer Therapeutic Has Been Included In The Top 100 Great Investigational Drug List 4/28/2006 10:54:22 AM    More...
Expression Genetics, Inc. Announces Enrollment Of First Patients In Phase I Clinical Trial Of Gene-Based IL-12 For Treatment Of Ovarian Cancer 10/19/2005 5:13:22 PM    More...